Flu virus changes every year, and that's why yearly vaccination is the most effective way to help prevent flu and its complications.
In this study, we will be working together to see if an investigational medicine is safe to use, and whether it can help people with overweight or obesity to lose weight and manage weight-related conditions. The investigational medicine is a monthly injection that is given subcutaneously (under the skin). Increasing physical activity and reducing the number of calories eaten does not necessarily lead to a reduction in weight for all individuals. As obesity continues to increase, this is a concern, as some diseases are known to occur more often in people with overweight or obesity.
Researchers are testing an investigational medicine for COVID-19. They want to know how well it may work and if it is safe in adults with COVID-19 who are at a higher risk for severe illness from COVID-19.
Join a clinical study testing the effects of an investigational oral drug on blood pressure.
To be eligible for the study, you must be diagnosed with RSV and enrolled within 3 days of your symptoms starting.
This study will investigate the safety and efficacy of a new investigational medicine in adults who are living with obesity or excess weight with at least one weight-related medical condition (such as cardiovascular disease (CVD) or high blood pressure).
We are looking for people who are affected by both hypertension and chronic kidney disease to participate in a research study to investigate a new experimental treatment. The research study is called EXPLORE-CKD
You may qualify if you:
- Have been diagnosed with hypertension and chronic kidney disease
- Are taking medication for hypertension
- Have abnormal kidney tests showing too much albumin (a type of protein) in your urine
Consider participating in the EXPLORE-CKD research study for a chance to contribute to research that may lead to more effective treatment options for high blood pressure and chronic kidney disease.
Choosing to participate in a clinical research study is an important decision. The information obtained from the EXPLORE-CKD study may help advance the treatment of future patients with high blood pressure and chronic kidney disease; and will provide important information about how well people respond to the study drug being investigated.
All clinical research studies are highly regulated to try to protect your safety and human rights. The research team can help explain this to you in further detail so that you are fully informed about the study before you decide whether you would like to participate.
What do I do next?
The EXPLORE-CKD Clinical Study is currently looking for interested study participants.
FOR MORE INFORMATION
Active-controlled study to assess the efficacy, safety, and tolerability of investigational drug Baxdrostat in combination with Dapagliflozin compared with Dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.
Study to Evaluate the Efficacy, Safety and Tolerability of Balcinrenone in Combination with Dapagliflozin Compared with Dapagliflozin in Patients with Chronic Kidney Disease and Albuminuria.
We are looking for subjects who are affected by uncontrolled hypertension to participate in a research study to investigate a new experimental treatment.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)